10x genomics stock price.

For 10x Genomics stock forecast for 2023, 2 predictions are offered for each month of 2023 with average 10x Genomics stock forecast of $38.85, a high forecast of $38.92, and a low forecast of $38.77. The average 10x Genomics stock forecast 2023 represents a 0.87% increase from the last price of $38.5099983215332.Find the specific products you need, along with their product code/SKU. Filter by product and workflow configuration.The 10x Genomics stock price is 35.48 USD today. How to buy 10x Genomics stock online? You can buy 10x Genomics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks. 14-Day Historical Data Date Opening Closing Minimum Maximum; Oct-24: 40.08: 40.42: 41.11: 39.89: Oct-25: 39.64: 37.04: 39.64: 36.92:Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.

Jul 15, 2022 · Shares of 10x Genomics are in a yearlong rut. After the company went public in 2019, its shares soared to a peak in mid-2021. Since then, however, TXG stock has generally trended down. However, the company has seen a 1.19% increase in its stock price over the last five trading sessions. Seeking Alpha reported 2023-11-04 that 10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. …Currently, 10X Genomics Inc does not have a price-earnings ratio. 10X Genomics Inc’s trailing 12-month revenue is $568.4 million with a -30.3% net profit margin. Year-over-year quarterly sales growth most recently was 28.1%. ... Overall, 10X Genomics Inc stock has a Value Score of 6, Estimate Revisions Score of 27 and Quality Score of 66.

10x Genomics appears to be significantly undervalued based on the GF Value calculation. At its current price of $47.68 per share, the stock's long-term return is likely to be much higher than its ...10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently down 8.66% so far this month. During the month of April, 10X Genomics Inc’s stock price has reached a high of $55.58 and a low of $50.49. Over the last year, 10X Genomics Inc has hit prices as high as $56.42 and as low as $23.81. Year to date, 10X Genomics Inc’s ...

That's 0.90% of their equity portfolio (27th largest holding). The investor owns 2.87% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q2 2020. Since then Cathie Wood bought shares six more times and sold shares on seven occasions. The investor's estimated purchase price is $397 Million, resulting in a loss of 67%.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.As of May 03, 2023, 4:00 PM CST, 10X Genomics Inc’s stock price was $54.00. 10X Genomics Inc is up 4.53% from its previous closing price of $51.66. During the last market session, 10X Genomics Inc’s stock traded between $51.36 and $52.42. Currently, there are 114.77 million shares of 10X Genomics Inc stock available for purchase.Best stock to buy now Best stock to buy now - 23.05.2023 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genom Best stock to buy now - …As of Dec. 31, 10x had $219.7 million in cash and cash equivalents, $210.2 million in marketable securities, and $2.6 million in restricted cash. 10x Genomics expects full-year 2023 revenue to be in the range of $580 million to $600 million, representing 12 percent to 16 percent growth over 2022 revenue.

UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. ... Consensus Price Target is the stock price analysts ...

PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial ...Nov 7, 2023 · Future criteria checks 4/6. 10x Genomics is forecast to grow earnings and revenue by 57.1% and 14% per annum respectively. EPS is expected to grow by 57.5% per annum. Return on equity is forecast to be -13.2% in 3 years. Dec 1, 2023 · Summary of all time highs, changes and price drops for 10x Genomics; Historical stock prices; Current Share Price: US$45.75: 52 Week High: US$63.57: 52 Week Low: US ... TXG stock returns are also predicted based on historical data. According to our research, TXG stock is a bad long-term investment. TXG share price has been in a bear cycle for the past year. 10x Genomics, Inc. stock trend is negative.Quotes. +8.40%. Delayed Quote Deutsche Boerse AG, November 21, 2023 at 09:41 am EST. More quotes. 10x Genomics, Inc. is a life science technology company. The Company's integrated platform solutions include instruments, consumables and software for analyzing biological systems.PLEASANTON, Calif., July 13, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the second quarter 2023 after market close on Thursday, August 3, 2023.The company will host a conference call and live webcast for analysts and …Barclays reduced their price target on shares of 10x Genomics from $66.00 to $47.00 and set an “overweight” rating for the company in a research report on Friday, September 29th. Finally, Citigroup boosted their price target on shares of 10x Genomics from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday ...

Trading volume was 3.9 million shares, already about triple the full-day average of about 1.3 million shares. 10x's rating was cut by de Bruin to underperform from neutral, and the stock price ...Analyst Michael Ryskin of Bank of America Securities reiterated a Sell rating on 10x Genomics (TXG – Research Report), with a price target of $36.00. Michael Ryskin has given his Sell rating due ...On average, Wall Street analysts predict. that 10x Genomics's share price could reach $58.67 by Sep 29, 2024. The average 10x Genomics stock price prediction forecasts a potential upside of 65.35% from the current TXG share price of $35.48 .10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on ...

Regardless, money keeps flowing into the gene editing space, and these three CRISPR stocks are worthy of investors’ attention going forward. CRSP. CRISPR. $57.47. EDIT. Editas. $11.70. TXG. 10x ...

Don’t write all synthetic biology stocks off just because the meme stocks crashed and burned! Here are 3 DNA stocks to buy for the synthetic biology revolution. TXG. 10x Genomics. $52.64. CRL ...10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently down 8.01% so far this month. During the month of April, 10X Genomics Inc’s stock price has reached a high of $55.54 and a low of $51.16. Over the last year, 10X Genomics Inc has hit prices as high as $82.96 and as low as $23.81. Year to date, 10X …Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023. SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research... 4 weeks ago - …This is an initial public offering of shares of Class A common stock by 10x Genomics, Inc. ... stock and our stock price may be more volatile. In addition, the ...As of August 31, 2023, the average one-year price target for 10x Genomics Inc - is 64.00. The forecasts range from a low of 30.30 to a high of $78.75. The average price target represents an ...Buy. 64.3%. Hold. 21.4%. Sell. 14.3%. View the real-time TXG price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd.co/fees to learn more.May 26, 2021 · The 10X Genomics stock forecast for tomorrow is $ 43.18, which would represent a -0.43% loss compared to the current price. In the next week, the price of TXG is expected to increase by 1.84% and hit $ 44.16. As far as the long-term 10X Genomics stock forecast is concerned, here’s what our ... Some 10x Genomics, Inc. shareholders may be a little concerned to see that the Chief Commercial Officer, James Wilbur, recently sold a substantial US$619k worth of stock at a price of US$42.09 per share.Probably the most concerning element of the whole transaction is that the disposal amounted to 87% of their entire holding. View our …

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Stock Price Statistics The stock price has increased by +23.81% in the last 52 weeks. The beta is 1.84, so 10x Genomics's price volatility has been higher than the market average.

10x Genomics Inc experienced a daily loss of 5.62% and a 3-month loss of 12.81%.The company also reported a Loss Per Share of 1.49. Despite these figures, we aim to explore whether the stock is ...What is the target price for 10x Genomics (TXG) stock? The latest price target for 10x Genomics ( NASDAQ: TXG) was reported by Barclays on Friday, September 29, 2023. The analyst firm set a price ... See the latest 10x Genomics Inc Ordinary Shares - Class A stock price (0A88:LTS), related news, valuation, dividends and more to help you make your investing decisions.PLEASANTON, Calif., Nov. 2, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended ...Buy 10X Genomics Stock. 10X Genomics is a health information services business based in the US. 10X Genomics shares (TXG.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $45.75 – an increase of 5.12% over the previous day. 10X Genomics employs 1,243 staff and has a trailing 12-month revenue of ...10x Genomics, Inc. (TXG) Stock Price, Quote & News - Stock Analysis 43.36 +0.01 (0.02%) At close: Nov 24, 2023, 1:00 PM 43.07 -0.29 (-0.67%) After-hours: …Nov 17, 2023 · 10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 19.53% so far this month. During the month of November, 10X Genomics Inc’s stock price has reached a high of $42.25 and a low of $33.79. Over the last year, 10X Genomics Inc has hit prices as high as $63.57 and as low as $31.28. Year to date, 10X Genomics Inc’s ... Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to ...

Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across …10x Genomics last issued its earnings results on November 2nd, 2023. The reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.45) by $0.06. The business had revenue of $153.64 million for the quarter, compared to the consensus estimate of $150.11 million. 10x Genomics has generated ($1.91) …Historical daily share price chart and data for 10x Genomics since 2019 adjusted for splits and dividends. The latest closing stock price for 10x Genomics as of November 30, 2023 is 43.52.. The all-time high 10x Genomics stock closing price was 202.37 on April 26, 2021.; The 10x Genomics 52-week high stock price is 63.57, which is 46.1% above the …About 10x Genomics 10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics ...Instagram:https://instagram. kennedy half dollar coins valuewatson x ibmbest flood insurance companies in floridanysearca ivv 0A88:LSELondon Stock Exchange. 10X Genomics Inc. Actions. Add to watchlist; Add to portfolio; Add an alert. Price (USD)43.95; Today's Change0.00 / 0.00%; Shares ... benefits of opening an llc in delawaretreasury note auction schedule 10x Genomics Inc experienced a daily loss of 5.62% and a 3-month loss of 12.81%.The company also reported a Loss Per Share of 1.49. Despite these figures, we aim to explore whether the stock is ... trade aries UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.Oct 10, 2023 · 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") has declined to issue a second preliminary injunction ... Stock analysis for 10X Genomics Inc (TXG*:BIVA) including stock price, stock chart, company news, key statistics, fundamentals and company profile.